DSO enforcement and risk

DSO enforcement can come from dental boards, state attorneys general, payers, federal and state false-claims authorities, contract litigation, and transaction diligence. False Claims Act matters are especially relevant when government-program claims are involved. Depending on the matter, defendants may include management companies, professional entities, owners, clinicians, or some combination.

​

Who enforces

Diligence can surface a corporate-practice issue even without a filed enforcement action, with possible consequences for pricing, escrows, closing conditions, or deal certainty. The sections below address recurring federal, state, and contract-law pathways; they are not an exhaustive list or a ranking of severity.

​

Why false-claims cases recur in dentistry

Several features of the dental business model can shape these cases:

1. Government-program claims create false-claims exposure. Pediatric Medicaid has been a recurring setting in the public dental enforcement record, making claim-level falsity, knowledge, and materiality central issues.
2. Clinical necessity may require retrospective review. Records, radiographs, treatment plans, consent documentation, and expert review may be needed to determine whether a procedure was necessary, performed, and coded correctly.
3. Fee-for-service billing creates claim-level volume. Production targets, incentives, or discipline that can influence clinical decisions may become evidence in an investigation, although compensation or utilization data alone do not establish a violation.

Several significant matters were initiated by current or former insiders, but the relator and procedural history should be verified matter by matter. In the Kool Smiles settlement, DOJ alleged that clinics disciplined “unproductive” dentists, paid cash bonuses to “productive” ones, and ignored dentists’ complaints about overutilization.¹

​

Recurring allegations and risk indicators

Several allegations and risk indicators recur across two decades of settlements, including FORBA/Small Smiles ($24M, 2010), MB2 ($8.45M, 2017), Kool Smiles/Benevis ($23.9M, 2018), ImmediaDent/Samson ($5.1M, 2018), and other matters in the tracker: These are recurring allegations and investigation signals, not elements of an offense and not a basis to infer fraud from a business model alone. Each matter turns on its claims, evidence, governing law, and procedural posture.

​

How corporate control becomes fraud liability

Medical necessity and services-not-rendered allegations recur in dental FCA matters. FCA liability requires proof of the applicable statutory elements; a causation theory must connect the entity’s conduct to the submission of false claims, and the government must establish statutory knowledge rather than mere negligence.² Policies, communications, incentives, complaint handling, and responses to identified billing problems may bear on entity knowledge, but none is automatically dispositive. Some complaints and settlement releases have linked alleged corporate-practice violations to false-claims theories. In the 2018 ImmediaDent/Samson matter, the government alleged that Samson violated Indiana’s corporate-practice law by improperly influencing clinical personnel through production rewards and discipline.³ The settlement resolved allegations without a determination of liability; it is neither a merits holding nor authority that every corporate-practice violation automatically makes a claim false. The 2013 Senate staff report separately recommended federal program-integrity measures directed at management companies alleged to circumvent state dentist-ownership laws.⁴

​

Federal remedies in the collected matters

The public record includes the following remedies and oversight responses. They are examples, not stages in a required sequence:

1. Settlement, including payment and remediation.
2. Settlement plus a corporate integrity agreement, often a five-year OIG compliance program with external review. MB2’s CIA bound its five owner-dentists personally.
3. CIA breach followed by exclusion. In 2014 OIG excluded CSHM, the successor manager of the Small Smiles chain, from federal health care programs for breaching the CIA: unreported quality events, missing corrective action, and a false compliance certification.⁵ Exclusion can be operationally devastating for a Medicaid-dependent organization; its precise scope and payment consequences turn on the exclusion order and applicable program rules.
4. CIA refused → public “high-risk” designation. ImmediaDent and Samson declined a proposed ten-year CIA, and OIG publicly declared them a continuing high risk with exclusion reserved.³

​

The second front: state attorneys general

State attorneys general have pursued corporate-practice and consumer-protection theories under state-specific law. The 2015 New York Aspen Dental settlement restricted percentage-of-profit fees, corporate control of clinical staffing, and noncompetes affecting clinical staff, making it an influential compliance reference beyond the settling parties.⁶ The May 2026 California Aspen judgment imposed defendant-specific terms addressing owner-succession control, revenue-based management fees, practice real estate, and sales incentives paid to clinical staff.⁷ The Carbon Health settlement and the California AG’s amicus position regarding a management company’s reserved replacement right are further California enforcement signals; they do not create a nationwide rule.⁸ Private plaintiffs may face threshold or cause-of-action obstacles that prevent a court from reaching the corporate-practice merits. The Treiber class action against Aspen was dismissed without reaching those merits, so its disposition does not decide whether the challenged structure complied with state professional-practice law.⁹ In Galkin v. SmileDirectClub, a succession agreement requiring a licensed-dentist successor and a management agreement with a clinical carve-out survived appellate review under New Jersey law.¹⁰ Together, the matters reinforce the need to analyze standing, claim elements, state law, contract language, and actual operations separately.

​

The third front: your own contract

Contract litigation can create material exposure without an agency action. If a management agreement violates applicable professional-practice law, a court may decline to enforce some or all of it, subject to state law, severability, and the claims and remedies before the court. In Dr. Allison, Dentist, Inc. v. Allison (Ill. 1935), a corporation operating a Chicago dental office through an employed dentist sued to enforce his noncompete and lost. The court held that the corporation could not practice dentistry, that employing a dentist to operate the office constituted practice, and that equity would not enforce a covenant tied to an illegal business.¹¹ Decades later, courts applying the laws of Texas, Washington, Colorado, and South Carolina held particular Orthodontic Centers of America business-services agreements void as unlicensed corporate practice, and the Fifth Circuit affirmed the Texas ruling.¹² In Packard v. OCA, the Fifth Circuit then rejected the equitable recovery theories before it after the contracts were declared illegal.¹³ These decisions show that an unlawful agreement may jeopardize both enforcement and recovery, but the applicable law and claims still matter. The OCA decisions illustrate a management-side risk: once the challenged agreements were held illegal, OCA could not obtain the contract or equitable recovery it sought. They do not establish that every fee receivable, transfer restriction, restrictive covenant, or related agreement fails whenever one provision is defective. Outcomes depend on the governing state’s law, severability, the contracts at issue, and the remedies pleaded. That uncertainty is why MSA legality and actual operational compliance are central diligence issues in DSO financings and transactions.

​

A calibrated risk picture

The authorities collected here do not establish that every dentist-owned-PC-plus-DSO arrangement is unlawful. The unpublished, nonprecedential Galkin panel affirmed judgment for the defendants on its New Jersey record,¹⁰ while the OCA decisions refused enforcement of specific agreements under the law applicable in those cases. Settlements and stipulated resolutions can be important enforcement signals, but they are not generally binding precedent and ordinarily do not establish liability beyond any express admissions or adjudicated terms. Size, sponsor type, and use of a management model do not by themselves establish liability. Recurring risk indicators in the public record include:

• Production quotas, bonuses, or discipline applied to dentists and hygienists by the management entity
• High pediatric Medicaid claim volume, which can magnify exposure when claim defects exist
• Clinical scheduling, staffing, and treatment-mix decisions made outside the practice
• Percentage-of-revenue fees where state professional-practice or fee-splitting law restricts the arrangement
• Complaints from dentists or staff that are documented without investigation or remediation, creating whistleblower and audit risk

Controls that can reduce risk:

1. Keep management incentives and discipline from overriding clinical judgment. Review any production-based compensation or quota arrangement under applicable state and federal law.
2. A dentist-owner with genuine clinical authority who exercises it, and a succession design with limited triggers and dentist-defined successors.
3. A state-law and fair-market-value analysis of the fee methodology. Do not assume that a cost-plus, flat, or percentage formula is universally permissible.
4. A functioning clinical-complaint channel with documented investigation, escalation, remediation, and non-retaliation controls.
5. An annual corporate practice self-audit against current state law, contract terms, actual operations, and relevant enforcement guidance.

Risk may surface through diligence, a payer audit, an employee or clinician complaint, contract litigation, or an agency investigation. Periodic agreement review, paired with testing of actual operations against the documents, is a core compliance control.

​

Sources

1. DOJ, Benevis and Kool Smiles clinics pay $$23.9 million (Jan. 10, 2018).
2. 31 U.S.C. § 3729(a)(1)(A)–(B); DOJ, FORBA $$24 million settlement (Jan. 20, 2010).
3. USAO W.D. Ky., ImmediaDent / Samson Dental Partners settlement (Nov. 6, 2018); OIG, CIA-refusal entry.
4. Senate Committee on Finance & Sen. Grassley, Joint Staff Report on the Corporate Practice of Dentistry in the Medicaid Program, S. Prt. 113-16 (June 2013).
5. HHS-OIG, OIG excludes pediatric dental management chain (Apr. 3, 2014).
6. NY AG, settlement with Aspen Dental Management (June 18, 2015).
7. California AG, settlement with Aspen Dental over corporate practice (May 7, 2026); DLA Piper, CPOM enforcement: new pressure points (July 2026).
8. California AG, Carbon Health settlement (June 2026).
9. Treiber v. Aspen Dental Management, Inc., 94 F. Supp. 3d 352 (N.D.N.Y. 2015), aff’d, 635 F. App’x 1 (2d Cir. 2016) (summary order).
10. Galkin v. SmileDirectClub, LLC, No. A-2867-19 (N.J. App. Div. June 11, 2021), official unpublished opinion.
11. Dr. Allison, Dentist, Inc. v. Allison, 360 Ill. 638, 196 N.E. 799 (1935). Opinion.
12. Penny v. OrthAlliance, Inc., 255 F. Supp. 2d 579 (N.D. Tex. 2003), opinion; In re OCA, Inc., 552 F.3d 413 (5th Cir. 2008), opinion. Full canon at DSO & dental case law.
13. Packard v. OCA, Inc., 624 F.3d 726 (5th Cir. 2010). Opinion.